This study is looking at a support or therapy approach for people with Schizophrenia with auditory verbal hallucinations, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.
In Switzerland
SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Switzerland
Sponsor
University Hospital of Psychiatry Bern (Switzerland)
This study is looking at whether a digital support tool can help people with Attention Deficit Disorder With Hyperactivity or Executive Function Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
In Shanghai
ADHDDrugA study involving a medication or substance.From 6 Years to 12 Years
This study is looking at whether NEUROFEEDBACK-MINDFULNESS can help people with Anxiety, Stress, or Academic Performance. Participants take part in NEUROFEEDBACK-MINDFULNESS and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia, bipolarity, Alzheimer Disease, or Ftd. Taking part may give some people access to a digital support tool with regular follow-up, but direct benefit is not guaranteed.
In Bron
Schizophrenia, BipolarityDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 45 Years to 80 Years
This study is looking at whether 1 can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether 1 can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.